News tagged with american society of clinical oncology
Related topics: cancer , cancer patients , chemotherapy
Poliovirus vaccine trial shows early promise for recurrent glioblastoma
An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
Cancer
May 21, 2013 |
not rated yet |
0
ASCO: combo antibody therapy effective for melanoma
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer
May 17, 2013 |
not rated yet |
0
Doctors should discuss financial concerns of cancer patients, study finds
(Medical Xpress)—Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at ...
Cancer
May 17, 2013 |
not rated yet |
0
New drug may help immune system fight cancer
(HealthDay)—An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
Cancer
May 16, 2013 |
5 / 5 (3) |
0
|
Study finds broad support for rationing of some types of cancer care
The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study ...
Cancer
May 15, 2013 |
not rated yet |
0
Preclinical tests shows agent stops 'slippery' proteins from binding, causing Ewing sarcoma
Continuous infusion of a novel agent not only halted the progression of Ewing sarcoma in rats, while some tumors also regressed to the point that cancer cells could not be detected microscopically, say researchers at Georgetown ...
Cancer
May 15, 2013 |
not rated yet |
0
PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced ...
Cancer
May 15, 2013 |
not rated yet |
0
Program linked to medical oncology practice improvement
(HealthDay)—For medical oncology practices in the United States, participation in the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI) correlates with improvements in ...
Cancer
Apr 06, 2013 |
not rated yet |
0
ASCO: anticoagulant use predicts metastatic prostate CA survival
(HealthDay)—Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of metastatic castration-resistant prostate cancer (mCRPC), according to ...
Cancer
Feb 19, 2013 |
not rated yet |
0
'Watch and wait' approach often best for older patients with kidney cancer
(HealthDay)—Sometimes, simply watching and waiting is a safe alternative to surgery for older patients with small kidney tumors, a new study suggests.
Cancer
Feb 13, 2013 |
not rated yet |
0
Too much sitting may lower odds of surviving colon cancer
(HealthDay)—People diagnosed with colorectal cancer who spend a lot of their leisure time sitting have a higher risk of dying, according to researchers at the American Cancer Society.
Cancer
Jan 23, 2013 |
not rated yet |
0
Physical activity cuts mortality in colorectal cancer survivors
(HealthDay)—For patients with invasive, non-metastatic colorectal cancer, increased recreational physical activity is associated with reduced all-cause mortality, while prolonged sedentary time correlates ...
Cancer
Jan 23, 2013 |
3 / 5 (1) |
0
Docetaxel significantly increases survival for incurable gastric cancers
Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, ...
Cancer
Jan 23, 2013 |
5 / 5 (1) |
0
Study shows drug combination extends pancreatic cancer patient survival
A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard ...
Cancer
Jan 22, 2013 |
5 / 5 (1) |
0
ASCO issues guideline for febrile neutropenia in adults
(HealthDay)—The American Society of Clinical Oncology has issued updated recommendations for both the prevention and management of febrile episodes in neutropenic oncology outpatients; the recommendations ...
Cancer
Jan 15, 2013 |
not rated yet |
0
